As a result of a research carried out within the scope of the joint program signed between the Azerbaijan National Academy of Sciences (ANAS) and TUBITAK, the possibility of using the cationic EQRPR peptide obtained based on the hydrolysis of rice, the bran protein and its mechanisms of action in the fight against cancer and COVID-19 infection were examined.